Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

  • Harvia’s Q1 revenue exceeded expectations, with c. 30% growth versus an analyst estimate of around 20%, and the growth was entirely organic. According to the analyst, the beat was broad-based across North America, Europe and Asia-Pacific, despite prior expectations of only modest euro-denominated growth in the US.
  • Middle East delivery disruptions linked to the war had only a minor impact, with the region representing about 2% of Harvia’s business. The analyst said the effect was limited to some delayed deliveries and may weigh somewhat on Q2 growth as well.
  • Harvia said the Muurame plant modernization will shift EUR 3-5 million of sales from Q2 to Q3. The analyst expects this to weaken Q2 profitability because production will be ramped down while the factory continues to incur personnel and changeover costs.
  • The analyst said Harvia’s strategy to expand from heaters toward broader sauna solutions, including steam and potentially infrared, should not materially dilute margins and could support long-term growth. Inderes lowered its recommendation from Buy to Accumulate after the share-price rise, citing a valuation of about P/E 22 for this year but still viewing the company positively.

This content is generated by AI based on a video transcript. You can give feedback on it in the Inderes forum.

Harvia Q1'26: A strong start to the year

Harvia's Q1 earnings exceeded our estimates, but the estimate changes for the full year remained small. Q2 earnings will be weighed down by the shift of revenue to Q3. We expect Harvia to continue its strong earnings growth and value creation in the coming years. Analyst Rauli Juva summarizes.